Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 35
Filtrar
Mais filtros

Medicinas Complementares
Intervalo de ano de publicação
1.
J Glob Health ; 10(1): 010503, 2020 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-32257158

RESUMO

Diarrheal disease remains a leading cause of child death globally, especially in low and middle-income countries. Use of oral rehydration solution (ORS) for treatment of diarrhea in children, a very cost-effective intervention, remains below 50% in many countries. Here we use a multi-level longitudinal model to reveal important predictors of ORS use at the national level. The findings suggest that increasing government effectiveness along with increased implementation and affordability of community-based health programs can lead to substantial increases in ORS use. Key informant interviews with national health leaders in countries that significantly improved ORS coverage support these quantitative findings.


Assuntos
Diarreia/terapia , Hidratação , Soluções para Reidratação/uso terapêutico , Criança , Pré-Escolar , Planejamento em Saúde Comunitária , Humanos , Programas Nacionais de Saúde , Soluções para Reidratação/administração & dosagem
2.
Nutrients ; 10(9)2018 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-30200394

RESUMO

The efficacy of oral rehydration solution (ORS) enriched with Lactobacillus reuteri DSM 17938 and zinc in infants with acute gastroenteritis, is poorly defined. The aim of this double-blind, randomized, placebo-controlled study, was to assess the efficacy of an ORS enriched with Lactobacillus reuteri DSM 17938 and zinc (ORS⁺Lr&Z) in well-nourished, non-hospitalized infants with acute diarrhoea. Fifty one infants with acute diarrhoea were randomly assigned to receive either ORS⁺Lr&Z (28 infants, mean ± SD age 1.7 ± 0.7 years, 21 males), or standard ORS (ORS-Lr&Z; 23 infants, mean ± SD age 1.8 ± 0.7 years, 16 males). Stools volume and consistency were recorded pre- and posttreatment using the Amsterdam Infant Stool Scale and were compared between the two groups, as well as lost work/day care days, drug administration and need for hospitalization. Both groups showed reduction in the severity of diarrhoea on day two (p < 0.001) while, all outcomes showed a trend to be better in the ORS⁺Lr&Z group, without reaching statistical significance, probably due to the relatively small number of patients. No adverse effects were recorded. In conclusion, both ORS were effective in managing acute diarrhoea in well-nourished, non-hospitalized infants. ORS enriched with L. reuteri DSM 17938 and zinc was well tolerated with no adverse effects.


Assuntos
Diarreia/terapia , Hidratação/métodos , Fenômenos Fisiológicos da Nutrição do Lactente , Limosilactobacillus reuteri/fisiologia , Probióticos/administração & dosagem , Soluções para Reidratação/administração & dosagem , Zinco/administração & dosagem , Doença Aguda , Administração Oral , Pré-Escolar , Diarreia/diagnóstico , Diarreia/microbiologia , Diarreia/fisiopatologia , Método Duplo-Cego , Feminino , Grécia , Humanos , Lactente , Masculino , Estado Nutricional , Probióticos/efeitos adversos , Soluções para Reidratação/efeitos adversos , Índice de Gravidade de Doença , Resultado do Tratamento , Equilíbrio Hidroeletrolítico , Zinco/efeitos adversos
3.
J Invest Surg ; 30(1): 33-40, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-27715338

RESUMO

AIM OF THE STUDY: To investigate the pulmonary oxidative stress and possible protective effect of N-Acetylcysteine (NAC) and Desferoxamine (DFX)in a porcine model subjected to hemorrhagic shock. MATERIALS AND METHODS: Twenty-one pigs were randomly allocated to Group-A (sham, n = 5), Group-B (fluid resuscitation, n = 8) and Group-C (fluid, NAC and DFX resuscitation, n = 8). Groups B and C were subjected to a 40-min shock period induced by liver trauma, followed by a 60-min resuscitation period. During shock, the mean arterial pressure (MAP) was maintained at 30-40 mmHg. Resuscitation consisted of crystalloids (35 mL/kg) and colloids (18 mL/kg) targeting to MAP normalization (baseline values ± 10%). In addition, Group-C received pretreatment with NAC 200 mg/kg plus DFX 2 g as intravenous infusions. Thiobarbituric Acid Reactive Substances (TBARS), protein carbonyls and glutathione peroxidase (GPx) activity were determined in lung tissue homogenates. Also, histological examination of pulmonary tissue specimens was performed. RESULTS: TBARS were higher in Group-B than in Group-A or Group-C: 2.90 ± 0.47, 0.57 ± 0.10, 1.78 ± 0.47 pmol/µg protein, respectively (p < 0.05). Protein carbonyls content was higher in Group-B than in Group-A or Group-C: 3.22 ± 0.68, 0.89 ± 0.30, 1.95 ± 0.54 nmol/mg protein, respectively (p > 0.05). GPx activity did not differ significantly between the three groups (p > 0.05). Lung histology was improved in Group-C versus Group-B, with less alveolar collapse, interstitial edema and inflammation. CONCLUSION: NAC plus DFX prevented the increase of pulmonary oxidative stress markers and protein damage after resuscitated hemorrhagic shock and had beneficial effect on lung histology. NAC/DFX combination may be used in the multimodal treatment of hemorrhagic shock, since it may significantly prevent free radical injury in the lung.


Assuntos
Acetilcisteína/uso terapêutico , Desferroxamina/uso terapêutico , Sequestradores de Radicais Livres/uso terapêutico , Pulmão/metabolismo , Estresse Oxidativo/efeitos dos fármacos , Choque Hemorrágico/tratamento farmacológico , Sideróforos/uso terapêutico , Acetilcisteína/administração & dosagem , Animais , Biomarcadores/análise , Coloides , Soluções Cristaloides , Desferroxamina/administração & dosagem , Modelos Animais de Doenças , Avaliação Pré-Clínica de Medicamentos , Hidratação/métodos , Glutationa Peroxidase/análise , Humanos , Infusões Intravenosas , Soluções Isotônicas/administração & dosagem , Pulmão/enzimologia , Pulmão/patologia , Masculino , Carbonilação Proteica/efeitos dos fármacos , Distribuição Aleatória , Soluções para Reidratação/administração & dosagem , Choque Hemorrágico/complicações , Suínos , Substâncias Reativas com Ácido Tiobarbitúrico/análise
5.
Curr Opin Gastroenterol ; 32(1): 18-23, 2016 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-26574867

RESUMO

PURPOSE OF REVIEW: Childhood diarrhea is the most common cause of morbidity and mortality, especially in the low and middle-income countries. The burden of child mortality because of diarrhea has declined, but still a lot is desired not only to reduce diarrhea-specific mortality but reduce the overall incidence, and hence the morbidity associated with childhood diarrhea. RECENT FINDINGS: A recent Lancet series on diarrhea suggests that amplification of the current interventions can eliminate virtually all preventable diarrhea deaths. A refocused attention and strategy and collective effort from the multilateral entities to promote water sanitation and hygiene, rotavirus vaccination, nutrition, and improved case management can bridge gaps and tackle the existing undue burden of deaths because of diarrhea. SUMMARY: Investment toward preventing and controlling childhood diarrhea should be a priority, especially when the existing solution is plausible for implementation at scale and in underprivileged settings.


Assuntos
Transtornos da Nutrição Infantil/prevenção & controle , Transtornos Cognitivos/prevenção & controle , Desidratação/prevenção & controle , Diarreia/prevenção & controle , Transtornos do Crescimento/prevenção & controle , Soluções para Reidratação/administração & dosagem , Abastecimento de Água/normas , Criança , Transtornos da Nutrição Infantil/complicações , Transtornos da Nutrição Infantil/microbiologia , Transtornos da Nutrição Infantil/mortalidade , Fenômenos Fisiológicos da Nutrição Infantil/imunologia , Pré-Escolar , Transtornos Cognitivos/etiologia , Transtornos Cognitivos/mortalidade , Desidratação/microbiologia , Desidratação/mortalidade , Países em Desenvolvimento , Diarreia/etiologia , Diarreia/mortalidade , Suplementos Nutricionais , Transtornos do Crescimento/etiologia , Transtornos do Crescimento/mortalidade , Prioridades em Saúde , Humanos , Imunização , Lactente , Áreas de Pobreza , Vacinas contra Rotavirus/administração & dosagem , Saneamento/normas
6.
Int J Sports Med ; 35(14): 1208-15, 2014 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-25203651

RESUMO

The purpose of the present study was to investigate the effect of carbohydrate-electrolyte solution (CE), lemon tea (LT), and distilled water (DW) on rehydration and cognitive performance after 60 min of moderate exercise. 9 healthy males and 10 eumenorrheic females completed 3 runs in a randomized crossover study design. During the 4-h recovery (REC) period, they consumed either a volume of CE, LT or DW equal to 150% of their body mass (BM) loss during the previous run. The 3 beverages vary in carbohydrate and electrolyte content. A battery of cognitive tests was performed upon arrival, immediately after exercise, and at the end of REC. After the REC, the restoration of BM loss was lower in the DW and LT trials than that in the CE trial in the female participants (CE vs. LT vs. DW: 59.3±2.8 vs. 41.7±5.7 vs. 45.6±2.2%). When compared with the DW, the accuracy of performances during a working memory task in both males and females was higher in the CE and LT trials. The results suggested that during a short-term recovery, both LT and CE show certain beneficial effect in maintaining cognitive performance. However, CE appears to be more effective than LT and DW in rehydrating female participants.


Assuntos
Bebidas , Cognição , Exercício Físico/fisiologia , Soluções para Reidratação/administração & dosagem , Adulto , Índice de Massa Corporal , Estudos Cross-Over , Carboidratos da Dieta/administração & dosagem , Água Potável/administração & dosagem , Eletrólitos/administração & dosagem , Feminino , Humanos , Masculino , Concentração Osmolar , Volume Plasmático , Potássio/sangue , Fatores Sexuais , Sódio/sangue , Chá , Urina , Adulto Jovem
8.
J Epidemiol Glob Health ; 4(1): 51-9, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-24534336

RESUMO

INTRODUCTION: Campylobacteriosis is one of the leading causes of gastroenteritis worldwide. This study describes the epidemiology of laboratory-confirmed Campylobacter diarrheal infections in two facility-based surveillance sites in Guatemala. METHODS: Clinical, epidemiologic, and laboratory data were collected on patients presenting with acute diarrhea from select healthcare facilities in the departments of Santa Rosa and Quetzaltenango, Guatemala, from January 2008 through August 2012. Stool specimens were cultured for Campylobacter and antimicrobial susceptibility testing was performed on a subset of isolates. Multidrug resistance (MDR) was defined as resistance to ≥3 antimicrobial classes. RESULTS: Campylobacter was isolated from 306 (6.0%) of 5137 stool specimens collected. For children <5 years of age, annual incidence was as high as 1288.8 per 100,000 children in Santa Rosa and 185.5 per 100,000 children in Quetzaltenango. Among 224 ambulatory care patients with Campylobacter, 169 (75.5%) received metronidazole or trimethoprim-sulfamethoxazole, and 152 (66.7%) received or were prescribed oral rehydration therapy. Antimicrobial susceptibilities were tested in 96 isolates; 57 (59.4%) were resistant to ciprofloxacin and 12 (12.5%) were MDR. CONCLUSION: Campylobacter was a major cause of diarrhea in children in two departments in Guatemala; antimicrobial resistance was high, and treatment regimens in the ambulatory setting which included metronidazole and trimethoprim-sulfamethoxazole and lacked oral rehydration were sub-optimal.


Assuntos
Antibacterianos/uso terapêutico , Infecções por Campylobacter/epidemiologia , Diarreia/epidemiologia , Farmacorresistência Bacteriana Múltipla , Combinação Trimetoprima e Sulfametoxazol/uso terapêutico , Adolescente , Adulto , Instituições de Assistência Ambulatorial , Campylobacter/isolamento & purificação , Infecções por Campylobacter/complicações , Infecções por Campylobacter/tratamento farmacológico , Criança , Pré-Escolar , Ciprofloxacina/uso terapêutico , Controle de Doenças Transmissíveis/métodos , Efeitos Psicossociais da Doença , Diarreia/tratamento farmacológico , Diarreia/microbiologia , Fezes/microbiologia , Feminino , Hidratação , Guatemala/epidemiologia , Humanos , Lactente , Recém-Nascido , Masculino , Metronidazol/uso terapêutico , Testes de Sensibilidade Microbiana , Pessoa de Meia-Idade , Soluções para Reidratação/administração & dosagem , Vigilância de Evento Sentinela , Adulto Jovem
9.
J Dairy Sci ; 95(11): 6677-86, 2012 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-22939792

RESUMO

The aim of this field study was to compare the efficacy and cost of 2 commercially available oral rehydration therapy (ORT) solutions in treating dairy calves with naturally acquired diarrhea. A total of 1,349 newborn Holstein-Friesian calves were prospectively enrolled in the study. Calves were housed in individual hutches and fed a mixture of pasteurized hospital milk and an all-milk protein milk replacer twice per day. Calves were monitored twice each day from d 2 of life until 30 d of age for the presence or absence of diarrhea, and were assigned a fecal score and a hydration score at each examination. Calves that developed mild to severe diarrhea that did not need intravenous fluids and did not have clinical evidence of concurrent disease (n = 360) were assigned randomly to receive 1 of 2 commercial ORT solutions: a hypertonic alkalinizing ORT containing lecithin-coated citrus fibers (Diaque, group D, n = 180; Boehringer Ingelheim, Ingelheim, Germany), and an isotonic nonalkalinizing ORT (RE-SORB, group R, n = 180; Pfizer Animal Health, New York, NY) for 2 to 8d; the duration of treatment depended on whether diarrhea was still present. No significant differences were observed in mortality rates or treatment failure rates between the 2 treatment groups. Fecal consistency returned to normal more quickly in group D calves than in group R calves; consequently, group D calves were treated for 1d less than were group R calves. The increase in body weight after 4d of treatment was larger in group D than in group R. The average daily gain from birth to weaning in calves that did not develop concurrent disease (such as pneumonia) during the study period tended to be higher in group D calves (0.53±0.11 kg/d) than in group R calves (0.51±0.09 kg/d). The smaller number of treatments at a lower cost per treatment produced a cost advantage of $4.82 per treated calf in group D calves compared with group R calves. Our findings support the concept that milk should continue to be fed to diarrheic calves that are being administered an ORT solution in order to maintain growth.


Assuntos
Doenças dos Bovinos/terapia , Diarreia/veterinária , Hidratação/veterinária , Soluções para Reidratação/uso terapêutico , Animais , Animais Recém-Nascidos , Peso Corporal , Bovinos , Citrus , Análise Custo-Benefício , Desidratação/terapia , Desidratação/veterinária , Diarreia/terapia , Fibras na Dieta/uso terapêutico , Fezes , Feminino , Hidratação/economia , Hidratação/métodos , Lecitinas/uso terapêutico , Masculino , Soluções para Reidratação/administração & dosagem
10.
Ann Trop Med Parasitol ; 104(6): 465-74, 2010 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-20863435

RESUMO

Cholera diarrhoea remains a major global health problem that has caused seven pandemics. The pathogenesis of cholera is attributable to the production of cholera toxin by the causative pathogen, Vibrio cholerae. The toxin causes increased production of cyclic adenosine monophosphate and this results in massive water and electrolyte secretion into the intestinal lumen. These changes manifest clinically as the painless defecation of voluminous stools that resemble 'rice water', leading to severe dehydration. The cornerstone in the management of cholera diarrhoea is the use of oral rehydration solutions (ORS) to replace the water and electrolytes lost as stools. The World Health Organization recommends the use of ORS of 'reduced osmolarity' for the treatment of acute non-cholera diarrhoea and the use of rice-based ORS for the management of cholera diarrhoea. Although several attempts have been made to improve ORS, studies to evaluate some of the modifications, which include the addition of amylase-resistant starch, the use of amino acids (such as glycine, alanine and glutamine) as sodium cotransporters, and zinc-supplemented ORS, are still needed.


Assuntos
Cólera/complicações , Desidratação/terapia , Diarreia/terapia , Hidratação/métodos , Soluções para Reidratação/administração & dosagem , Soluções para Reidratação/química , Desidratação/etiologia , Diarreia/etiologia , Humanos , Concentração Osmolar
11.
J Med Food ; 13(3): 605-9, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20438327

RESUMO

Among honey's benefits are its anti-inflammatory and antimicrobial effects. Because gastroenteritis is an acute inflammation of the gastrointestinal tract that may be caused by a variety of microbes, the aim of the present study was to verify whether the addition of honey in oral rehydration solution (ORS) could affect the duration of symptoms of acute gastroenteritis in infants and children. One hundred infants and children with acute gastroenteritis were randomly assigned to one of two treatment groups, each consisting of 50 patients: Group I received ORS for rehydration (control), and Group II received ORS with honey. The mean ages of patients of Groups I and II were 1.5 +/- 1.2 and 1.1 +/- 0.8 years, respectively. In the honey-treated group the frequencies of vomiting and diarrhea were significantly reduced compared to the control group (P < .001 and P < .05, respectively). Also, the recovery time, defined as the number of hours from initiation of treatment to when normal soft stools are passed, with the patient showing normal hydration and satisfactory weight gain, was significantly shortened after honey ingestion (P < .001). In conclusion, honey added to ORS promoted rehydration of the body and sped recovery from vomiting and diarrhea.


Assuntos
Hidratação , Gastroenterite/tratamento farmacológico , Mel , Soluções para Reidratação/administração & dosagem , Administração Oral , Animais , Abelhas , Criança , Pré-Escolar , Feminino , Humanos , Lactente , Masculino
12.
Ann Fr Anesth Reanim ; 29(1): 25-35, 2010 Jan.
Artigo em Francês | MEDLINE | ID: mdl-20096535

RESUMO

Fluid loading is the first step, necessary to care for severe sepsis. Two main classes of solutions are currently available: crystalloids and colloids. The concept of small volume resuscitation with hypertonic saline has emerged these last years in the care of traumatic haemorrhagic shock. The main benefits are the restoration of intravascular volume, improvement of cardiac output and improvement of regional circulations. Many experiments highlight modulation of immune and inflammatory cascades. We report the mechanisms of action of hypertonic saline based on experimental human and animal studies, which advocate its use in septic shock.


Assuntos
Hidratação , Substitutos do Plasma/uso terapêutico , Soluções para Reidratação/uso terapêutico , Solução Salina Hipertônica/uso terapêutico , Choque Séptico/terapia , Animais , Adesão Celular/efeitos dos fármacos , Ensaios Clínicos como Assunto , Avaliação Pré-Clínica de Medicamentos , Edema/prevenção & controle , Endotélio Vascular/efeitos dos fármacos , Hemodinâmica/efeitos dos fármacos , Interações Hospedeiro-Patógeno/efeitos dos fármacos , Humanos , Sistema Imunitário/efeitos dos fármacos , Inflamação/tratamento farmacológico , Inflamação/fisiopatologia , Leucócitos/efeitos dos fármacos , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Insuficiência de Múltiplos Órgãos/etiologia , Insuficiência de Múltiplos Órgãos/prevenção & controle , Substitutos do Plasma/administração & dosagem , Substitutos do Plasma/efeitos adversos , Substitutos do Plasma/farmacologia , Soluções para Reidratação/administração & dosagem , Soluções para Reidratação/efeitos adversos , Soluções para Reidratação/farmacologia , Ressuscitação/métodos , Solução Salina Hipertônica/administração & dosagem , Solução Salina Hipertônica/efeitos adversos , Solução Salina Hipertônica/farmacologia , Choque Séptico/complicações , Choque Séptico/fisiopatologia , Suínos
13.
Arch. venez. pueric. pediatr ; 72(1): 20-25, ene.-mar. 2009. tab
Artigo em Espanhol | LILACS | ID: lil-589217

RESUMO

La diarrea es una causa principal de morbi-mortalidad en niños y el uso de la terapia de rehidratación oral (uso de suero oral más líquidos caseros) puede prevenir la deshidratación. Identificar las soluciones caseras utilizadas en los niños con diarrea sin deshidratación, analizar su composición bioquímica y proponer las más adecuadas. Se entrevistaron 167 madres, en consultas pediátricas, seleccionadas al azar, durante los años 2004-2006, en Mérida-Venezuela; es un estudio epidemiológico, analítico, prospectivo y concurrente. Se identificaron cinco grupos de soluciones caseras: agua de arroz, sopa de plátano, sopa de cambur (banana), infusiones de hierbas y jugos de frutas. El análisis bioquímico se realizó mediante un pH metro, espectroscopia de absorción atómica (Na y K), argentometría (Cl), osmómetro (osmolaridad), glucosa peroxidasa (glucosa), hidrovolumetría por neutralización (bicarbonato) y bandas de absorción (citrato), procesadas en la Facultad de Ciencias de la Universidad de Los Andes. Todas las soluciones estudiadas tienen un pH ácido, con excepción del suero casero con bicarbonato. las concentraciones de electrolitos fueron mínimas en el agua de arroz, las infusiones de hierbas y los jugos de frutas, mientras que fueron más elevadas en las sopas de plátano y banana. (Na y Cl más elevado). Las osmolaridad fue baja en todas las soluciones y alta en los jugos de frutas. Ninguna de las soluciones reúne las concentraciones planteadas por la OMS, aunque en el niño con diarrea sin deshidratación la sopas de plátano y banana pueden ser utilizadas debido a la buena aceptación y al bajo costo. No se recomiendan los jugos de fruta por su alta osmolaridad.


Diarrhoea continues to be one the main causes of morbidity-mortality in latin american countries due to dehydration. this is why the most important strategy to avoid deaths due to dehydration is oral rehydration therapy (oral rehydration solution plus homemade solutions) which may vary according to each region of the country. To identify the most frequently used homemade solutions for preventing dehydration in children with acute diarrhoea within the community in Mérida, Venezuela; to analyze the biochemical composition of these solutions; to propose the use of the most adequate ones. By means o an epidemiological, analytical, prospective and concurrent study 167 inquiries were performed to mothers who sought medical help in the main assistance centers of the city. these mothers were selected randomly during 2004-2006. five groups of homemade solutions were identified: rice water (golden rice in esther grain or flour), plantain soup with or without chicken, banana soup, herbal infusions and fruit juices. Biochemical analysis was performed by means of: ohmmeters (pH), spectroscopy of atomic absorption (Na and K), argentometry (Cl), osmometer (osmolarity), glucose peroxidase (glucose), hidrovolumetry by neutralization (bicarbonate) and absorption bands (citrate) processed at the Science Faculty of the Universidad de Los Andes. All the homemade liquids have an acidic pH, except solutions with added bicarbonate. electrolytes concentrations were minimum except for the plantain and banana soups, which have a higher sodium and chloride concentration. The osmolarity of most solutions was low, with exception of fruit juices (orange and guava). Conclusions: none of the homemade solutions meet the requirements established by the World Health Organization as an ideal rehydration solution. However, plantain and banana soup may be used in children with diarrhea without dehydration due to their high availability.


Assuntos
Humanos , Masculino , Feminino , Criança , Diarreia Infantil/etiologia , Diarreia Infantil/terapia , Musa/química , Oryza/química , Plantas Medicinais/química , Soluções para Reidratação/administração & dosagem , Soluções para Reidratação/química , Cuidado da Criança , Composição de Alimentos , Medicina Tradicional
14.
J Am Acad Nurse Pract ; 20(8): 402-6, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18786014

RESUMO

PURPOSE: To review current literature on the effectiveness of oral rehydration therapy (ORT) in the treatment of mild to moderate dehydration in children. DATA SOURCES: Recommendations from American Academy of Pediatrics (AAP), World Health Organization (WHO), selected research articles (2000-2006), and Internet sources. CONCLUSIONS: Dehydration is a common diagnosis in pediatric primary care. The literature indicates that dehydration is more often treated with intravenous (IV) therapy when ORT would be equally effective. ORT is an effective treatment for children with mild to moderate dehydration. ORT could be used more frequently rather than IV rehydration therapy. The use of ORT versus traditional methods of IV hydration matches the nursing philosophy of holistic care by enhancing client comfort and autonomy. IMPLICATIONS FOR PRACTICE: Current practice in the treatment of mild to moderate dehydration in children does not match both AAP and WHO guidelines, which are based on evidence supporting ORT effectiveness. Treatment with ORT allows children more flexibility to be treated at home and thus decreases hospital stay. Evidence shows that the time required to initiate ORT is actually quicker than IV therapy and allows for a less stressful therapy that can be performed in the home.


Assuntos
Desidratação/terapia , Hidratação/métodos , Profissionais de Enfermagem/organização & administração , Seleção de Pacientes , Atenção Primária à Saúde/métodos , Índice de Gravidade de Doença , Criança , Desidratação/diagnóstico , Desidratação/epidemiologia , Desidratação/etiologia , Prática Clínica Baseada em Evidências , Hidratação/enfermagem , Gastroenterite/complicações , Saúde Holística , Humanos , Infusões Intravenosas , Papel do Profissional de Enfermagem , Filosofia em Enfermagem , Guias de Prática Clínica como Assunto , Prevalência , Soluções para Reidratação/administração & dosagem , Resultado do Tratamento , Estados Unidos/epidemiologia
15.
Pediatrics ; 121(5): e1279-85, 2008 May.
Artigo em Inglês | MEDLINE | ID: mdl-18450870

RESUMO

OBJECTIVE: The purpose of this work was to evaluate whether education about zinc supplements and provision of zinc supplements to caregivers is effective in the treatment of acute diarrhea and whether this strategy adversely affects the use of oral rehydration salts. PATIENTS AND METHODS: Six clusters of 30,000 people each in Haryana, India, were randomly assigned to intervention and control sites. Government and private providers and village health workers were trained to prescribe zinc and oral rehydration salts for use in diarrheal episodes in 1-month-old to 5-year-old children in intervention communities; in the control sites, oral rehydration salts alone was promoted. In 2 cross-sectional surveys commencing 3 months (survey 2) and 6 months (survey 3) after the start of the intervention, care-seeking behavior, drug therapy, and oral rehydration salts use during diarrhea, diarrheal and respiratory morbidity, and hospitalization rates were measured. RESULTS: In the 2 surveys, zinc was used in 36.5% (n = 1571) and 59.8% (n = 1649) and oral rehydration salts in 34.8% (n = 1571) and 59.2% (n = 1649) of diarrheal episodes occurring in the 4 weeks preceding interviews in the intervention areas. In control areas, oral rehydration salts were used in 7.8% (n = 2209) and 9.8% (n = 2609) of episodes. In the intervention communities, care seeking for diarrhea reduced by 34% (survey 3), as did the prescription of drugs of unknown identity (survey 3) and antibiotics (survey 3) for diarrhea. The 24-hour prevalences of diarrhea and acute lower respiratory infections were lower in the intervention communities (survey 3). All-cause, diarrhea, and pneumonia hospitalizations in the preceding 3 months were reduced in the intervention compared with control areas (survey 3). CONCLUSIONS: Diarrhea is more effectively treated when caregivers receive education on zinc supplementation and have ready access to supplies of oral rehydration salts and zinc, and this approach does not adversely affect the use of oral rehydration salts; in fact, it greatly increases use of the same.


Assuntos
Diarreia/terapia , Soluções para Reidratação/administração & dosagem , Zinco/administração & dosagem , Administração Oral , Cuidadores/educação , Pré-Escolar , Países em Desenvolvimento , Diarreia Infantil/terapia , Hospitalização , Humanos , Índia , Lactente , Saúde da População Rural
16.
Zhonghua Er Ke Za Zhi ; 45(4): 252-5, 2007 Apr.
Artigo em Chinês | MEDLINE | ID: mdl-17706059

RESUMO

OBJECTIVE: To assess the efficacy and safety of reduced osmolarity oral rehydration salts (ROORS) in treatment of mild to moderate dehydration caused by acute diarrhea in children. METHODS: A multicenter, randomized, double-blind, positive drug controlled clinical trial was conducted in 125 cases aged 1 to 17 years. These children with acute diarrhea and signs of dehydration were randomly assigned to receive either ROORS (trial group, n = 62) or oral rehydration salts II (ORS II) (control group, n = 63). The volume of intravenous infusion were recorded. The improvements of systemic symtoms and signs, diarrhea, dehydration and total scores were compared between the two groups. The adverse events and changes of electrolyte and other laboratory tests during treatment were also observed and analyzed. RESULTS: The overall effective rates in trial group and control group were 96.8% and 96.8%, respectively. The recovery of systemic symptoms, dehydration signs and diarrhea occurred in 96%, 97% and 78% patients in trial groups, and 96%, 98% and 85% patients in control group. The scores of symptoms and signs in both groups decreased significantly after treatment. All the above parameters and the number of cases who needed intravenous infusion (41 vs. 39) were not statistically different between two groups. However, the average volume of intravenously infused fluids in trial group was (450.98 +/- 183.07) ml, 24.5% less than that in the control group (597.30 +/- 343.37) ml (P < 0.05). The mean serum Na(+) concentration elevated from (137.48 +/- 4.55) mmol/L to (139.52 +/- 3.25) mmol/L (P < 0.01) in control group after treatment, but the change was not statistically significant in trail group. Serum K(+), Cl(-), HCO(3)(-) and other laboratory result did not change significantly after treatment. The total scores in both groups decreased obviously after treatment, but no significant difference was demonstrated between two groups (P > 0.05). A case in trial group had mild abdominal distention and recovered spontaneously. CONCLUSION: ROORS was shown to be effective and safe in the treatment of mild and moderate dehydration induced by acute diarrhea. Compared to ORS II, ROORS could decrease the intravenous supplement of fluid and lower the risk of hypernatremia.


Assuntos
Desidratação/terapia , Diarreia/terapia , Hidratação/métodos , Soluções para Reidratação/administração & dosagem , Adolescente , Criança , Pré-Escolar , Cloretos/sangue , Desidratação/etiologia , Diarreia/complicações , Método Duplo-Cego , Feminino , Humanos , Lactente , Infusões Intravenosas , Masculino , Concentração Osmolar , Potássio/sangue , Sódio/sangue , Resultado do Tratamento , Equilíbrio Hidroeletrolítico
18.
Dis Colon Rectum ; 47(7): 1181-6, 2004 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-15164249

RESUMO

PURPOSE: Bowel preparation with oral sodium phosphate can cause symptomatic dehydration and electrolyte disturbances. This randomized, controlled trial was designed to evaluate whether carbohydrate-electrolyte (E-Lyte) solution enhanced bowel preparation and improved patient acceptance with oral sodium phosphate. METHODS: A total of 187 consecutive adults undergoing colonoscopy by two endoscopists were randomized to receive two packets of oral sodium phosphate (Fleet Phospho-soda) with or without additional supplement of a carbohydrate-electrolyte (E-Lyte) solution. All patients and endoscopists completed a standardized questionnaire. Urine-specific gravity and serum biochemistry were randomly performed in 150 and 50 patients, respectively. RESULTS: Ninety patients were randomized to have oral sodium phosphate with E-Lyte supplements (Group 1) and 94 patients to sodium phosphate without E-Lyte supplements (Group 2). The groups were similar in age and gender, indication for colonoscopy, and previous colonic surgery. Patients taking E-Lyte supplement had significantly less dizziness (none, 80 vs. 56 percent; P < 0.001) and a trend toward less nausea (none, 70 vs. 56 percent; P = 0.05). All patients in Group 1 completed the bowel preparation as opposed to 3 percent of Group 2 being unable to complete the preparation. Hypokalemia was significantly more frequent ( P = 0.008) in Group 2 patients without E-Lyte supplements. More patients in Group 2 needed intravenous rehydration (11 vs. 4 percent). Differences in serum creatinine and urine-specific gravity suggested possibly a lesser degree of hypovolemia in patients taking E-Lyte supplements. The quality of bowel cleansing in patients taking E-Lyte supplements was considered better by both the endoscopists and patients. CONCLUSIONS: Carbohydrate-electrolyte (E-Lyte) solution protects against hypokalemia, improves patient tolerability, and may enhance use of oral sodium phosphate as a bowel-preparation agent.


Assuntos
Catárticos/administração & dosagem , Intestinos/efeitos dos fármacos , Fosfatos/administração & dosagem , Soluções para Reidratação/administração & dosagem , Tensoativos/administração & dosagem , Administração Oral , Carboidratos/administração & dosagem , Colonoscopia , Eletrólitos/administração & dosagem , Feminino , Humanos , Hipopotassemia/prevenção & controle , Masculino , Pessoa de Meia-Idade , Aceitação pelo Paciente de Cuidados de Saúde , Cuidados Pré-Operatórios/métodos , Resultado do Tratamento
19.
Pediatr Infect Dis J ; 22(3): 229-34, 2003 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-12634583

RESUMO

BACKGROUND: Previous studies have shown a positive treatment effect of individualized homeopathic treatment for acute childhood diarrhea, but sample sizes were small and results were just at or near the level of statistical significance. Because all three studies followed the same basic study design, the combined data from these three studies were analyzed to obtain greater statistical power. METHODS: Three double blind clinical trials of diarrhea in 242 children ages 6 months to 5 years were analyzed as 1 group. Children were randomized to receive either an individualized homeopathic medicine or placebo to be taken as a single dose after each unformed stool for 5 days. Parents recorded daily stools on diary cards, and health workers made home visits daily to monitor children. The duration of diarrhea was defined as the time until there were less than 3 unformed stools per day for 2 consecutive days. A metaanalysis of the effect-size difference of the three studies was also conducted. RESULTS: Combined analysis shows a duration of diarrhea of 3.3 days in the homeopathy group compared with 4.1 in the placebo group (P = 0.008). The metaanalysis shows a consistent effect-size difference of approximately 0.66 day (P = 0.008). CONCLUSIONS: The results from these studies confirm that individualized homeopathic treatment decreases the duration of acute childhood diarrhea and suggest that larger sample sizes be used in future homeopathic research to ensure adequate statistical power. Homeopathy should be considered for use as an adjunct to oral rehydration for this illness.


Assuntos
Diarreia/diagnóstico , Diarreia/terapia , Homeopatia/métodos , Pré-Escolar , Terapia Combinada , Diarreia/mortalidade , Diarreia Infantil/diagnóstico , Diarreia Infantil/mortalidade , Diarreia Infantil/terapia , Método Duplo-Cego , Feminino , Hidratação/métodos , Humanos , Lactente , Masculino , Probabilidade , Prognóstico , Ensaios Clínicos Controlados Aleatórios como Assunto , Soluções para Reidratação/administração & dosagem , Medição de Risco , Sensibilidade e Especificidade , Índice de Gravidade de Doença , Análise de Sobrevida , Resultado do Tratamento
20.
Nutrition ; 18(6): 458-62, 2002 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12044816

RESUMO

OBJECTIVES: Recurring diarrhea and persistent diarrhea are commonly associated with malnutrition and long-term functional deficits. A beneficial approach would be to develop an alanyl-glutamine (AlaGln)-based oral rehydration and nutrition therapy (ORNT). We investigated the effect of an AlaGln-ORNT solution on electrolyte and water absorption in a rat model of secretory diarrhea induced by cholera toxin. METHODS: Phenolsulfonphthalein (50 microg/mL) was used as a non-absorbable marker for calculation of net water and electrolyte transport. Solutions tested were Ringer's solution, a glutamine-based ORNT (Gln-ORNT) solution, and an AlaGln-ORNT solution. Cholera toxin (1 microg/mL) was injected into lumen of rat small intestinal segments and incubated for 18 h before the initiation of the perfusion. RESULTS: Cholera toxin induced significant secretion of electrolyte and water in the control Ringer's solution. AlaGln-ORNT and Gln-ORNT solutions reduced the sodium secretory effect of cholera toxin by 128% and 36%, respectively. The net water secretion also was reduced by 95% and 60%, respectively, with the AlaGln-ORNT and Gln-ORTN solutions. CONCLUSIONS: These results showed that AlaGln-ORNT solution can enhance water and electrolyte intestinal absorption even better than glutamine or glucose and thus provide a potential novel approach for ORNT to break the vicious cycle of diarrhea and malnutrition. Clinical trials are now needed in children and adults with diarrhea and malnutrition.


Assuntos
Diarreia/terapia , Dipeptídeos/administração & dosagem , Eletrólitos/metabolismo , Absorção Intestinal/efeitos dos fármacos , Soluções para Reidratação/administração & dosagem , Água/metabolismo , Animais , Toxina da Cólera , Diarreia/induzido quimicamente , Diarreia/metabolismo , Dipeptídeos/uso terapêutico , Modelos Animais de Doenças , Feminino , Hidratação/métodos , Glutamina , Cinética , Masculino , Potássio/metabolismo , Ratos , Ratos Wistar , Soluções para Reidratação/uso terapêutico , Sódio/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA